130 related articles for article (PubMed ID: 21518511)
21. Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors.
Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):222-31. PubMed ID: 25193469
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
23. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation.
Lim JH; Kim SP; Gabrielson E; Park YB; Park JW; Kwon TK
Int J Cancer; 2005 Aug; 116(2):200-6. PubMed ID: 15800911
[TBL] [Abstract][Full Text] [Related]
24. Arsenic trioxide inhibits DNA methyltransferase and restores expression of methylation-silenced CDKN2B/CDKN2A genes in human hematologic malignant cells.
Fu HY; Shen JZ; Wu Y; Shen SF; Zhou HR; Fan LP
Oncol Rep; 2010 Aug; 24(2):335-43. PubMed ID: 20596618
[TBL] [Abstract][Full Text] [Related]
25. [DNA methylation regulates kir3dl1 gene expression in K562 cell line].
Gao XN; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):472-5. PubMed ID: 18549610
[TBL] [Abstract][Full Text] [Related]
26. [Two CpG-islands of SEMA3B gene: methylation in clear cell renal cell carcinoma].
Loginov VI; Khodyrev DS; Pronina IV; Maliukova AV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Zabarovskiĭ ER; Braga EA
Mol Biol (Mosk); 2009; 43(6):1088-92. PubMed ID: 20088387
[TBL] [Abstract][Full Text] [Related]
27. [Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].
Nakatsuka S; Takakuwa T; Aozasa K
Rinsho Byori; 2001 Dec; 49(12):1242-7. PubMed ID: 11797395
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.
Song SH; Jong HS; Choi HH; Inoue H; Tanabe T; Kim NK; Bang YJ
Cancer Res; 2001 Jun; 61(11):4628-35. PubMed ID: 11389100
[TBL] [Abstract][Full Text] [Related]
30. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin.
Li JL; Fei Q; Yu J; Zhang HY; Wang P; Zhu JD
Ai Zheng; 2004 Sep; 23(9):985-91. PubMed ID: 15363188
[TBL] [Abstract][Full Text] [Related]
31. Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies.
Nagai H; Li Y; Hatano S; Toshihito O; Yuge M; Ito E; Utsumi M; Saito H; Kinoshita T
Genes Chromosomes Cancer; 2003 Sep; 38(1):13-21. PubMed ID: 12874782
[TBL] [Abstract][Full Text] [Related]
32. Research on DNA methylation of human osteosarcoma cell MGMT and its relationship with cell resistance to alkylating agents.
Guo J; Cui Q; Jiang W; Liu C; Li D; Zeng Y
Biochem Cell Biol; 2013 Aug; 91(4):209-13. PubMed ID: 23859014
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B-cell but also in T- and natural killer (NK)/T-cell malignancies.
Nakatsuka S; Takakuwa T; Tomita Y; Hoshida Y; Nishiu M; Yamaguchi M; Nishii K; Yang WI; Aozasa K
Cancer Sci; 2003 Jan; 94(1):87-91. PubMed ID: 12708480
[TBL] [Abstract][Full Text] [Related]
34. [Effects of DNA methylation on expression of TIG1 gene in acute leukemia].
Wang Y; Zhang JY; Lin FR; Niu ZY; Zhou JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):648-52. PubMed ID: 24989270
[TBL] [Abstract][Full Text] [Related]
35. Gene silencing by DNA methylation in haematological malignancies.
Boultwood J; Wainscoat JS
Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
[TBL] [Abstract][Full Text] [Related]
36. Alterations of DNA methylation in hematologic malignancies.
Rush LJ; Plass C
Cancer Lett; 2002 Nov; 185(1):1-12. PubMed ID: 12142073
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
[TBL] [Abstract][Full Text] [Related]
38. The expression of RUNDC3B is associated with promoter methylation in lymphoid malignancies.
Burmeister DW; Smith EH; Cristel RT; McKay SD; Shi H; Arthur GL; Davis JW; Taylor KH
Hematol Oncol; 2017 Mar; 35(1):25-33. PubMed ID: 26011749
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
40. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme.
Martinez R; Setien F; Voelter C; Casado S; Quesada MP; Schackert G; Esteller M
Carcinogenesis; 2007 Jun; 28(6):1264-8. PubMed ID: 17272309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
